CME Group
$263.14Change from previous close: −0.74%Absolute change: −$1.96
At a glance
- Revenue growth
- +6.32%
- 2025 vs 2024
- Net income growth
- +15.50%
- 2025 vs 2024
- Net margin
- 62.6%
- 2024: 57.6%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 947 | 1,260 | 1,134 | 968 | 1,059 | 1,117 | 1,018 | 1,003 | 777 | 893 | 1,044 | 857 |
| Depreciation and amortization | 84.2 | 83.3 | 82.4 | 82.6 | 83.4 | 82.5 | 83.4 | 83.9 | 84.2 | 85.3 | 86.3 | 88.3 |
| Capital expenditure | -23.6 | -21.8 | -32.5 | -18.4 | -18.4 | -14.2 | -26.2 | -29.8 | -18.2 | -19.8 | -20.8 | -19.9 |
| Investing cash flow | -29.4 | -23.0 | 1,552 | -19.1 | -18.0 | -16.0 | -25.3 | -29.5 | -5.0 | -22.8 | -20.4 | -19.5 |
| Financing cash flow | -8,091 | 2,117 | 9,899 | 6,400 | 20,999 | 19,211 | -984 | 13,347 | -9,223 | 1,936 | 2,589 | -26,467 |
| Dividends paid | -468 | -2,698 | -455 | -455 | -455 | -2,567 | -419 | -419 | -419 | -2,328 | -400 | -400 |
| Share repurchases | -698 | -561 | -261 | -22.2 | -8.8 | -8.2 | -3.5 | -17.1 | -0.1 | -12.3 | -2.9 | -17.4 |
| Debt issued | 0.0 | 0.0 | 0.0 | -1.7 | 0.0 | 742 | — | — | — | — | — | — |
| Debt repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -750 | — | — | — | — | — | — |
| Net change in cash | -7,174 | 3,353 | 12,585 | 7,349 | 22,040 | 20,312 | 8.5 | 14,321 | -8,451 | 2,806 | 3,612 | -25,630 |
| Free cash flow | 924 | 1,238 | 1,101 | 950 | 1,040 | 1,102 | 992 | 973 | 759 | 873 | 1,024 | 837 |
| Levered free cash flow | 566 | 933 | 830 | 556 | 692 | -1,285 | 2,829 | 645 | 452 | -1,285 | 2,662 | 559 |